• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

GE HealthCare Launches AI-Powered Prostate Volume Assist for Ultrasound

News
Article

Featuring automated one-click functionality for capturing prostate volume, the AI-enabled software may help shorten workflows for prostate imaging, biopsies, and ultrasound-guided procedures.

An emerging artificial intelligence software may enable clinicians to quickly obtain automated measurements of prostate volume.

With the launch of Prostate Volume Assist, clinicians can ascertain prostate measurements and calculations with one click, according to GE HealthCare, the manufacturer of the software. The company said the Prostate Volume Assist can be beneficial with prostate imaging and ultrasound-guided procedures.

GE Healthcare Launches AI-Powered Prostate Volume Assist for Ultrasound

With the launch of Prostate Volume Assist, clinicians can ascertain prostate measurements and calculations with one click, according to GE HealthCare, the manufacturer of the software. (Image courtesy of GE HealthCare.)

“Normally, clinicians determine prostate volume through a manual, repetitive process that requires measuring multiple dimensions and applying a mathematical formula,” said Fredrik Gran, head of innovation, surgical visualization and guidance, ultrasound at GE HealthCare. “Prostate Volume Assist uses artificial intelligence to automate this process with a single click, and yield results in less than two seconds. This technology provides an added level of support for (clinicians) to improve efficiencies in the workflow and enable precision care.”

GE HealthCare noted that Prostate Volume Assist will be accessible via the company’s bkActiv, bk3000/5000 and bkSpecto ultrasound modalities.

Recent Videos
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
Detecting PCa Recurrence in African Americans: Can 18F-Flotufolastat Have an Impact?
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
Related Content
Multimodal AI with CCTA and MRI Data Shows Promise in Predicting MACE in Patients with Obstructive CAD

Multimodal AI with CCTA and MRI Data Shows Promise in Predicting MACE in Patients with Obstructive CAD

Jeff Hall
January 29th 2025
Article

For patients with newly diagnosed obstructive coronary artery disease (CAD), a multimodal machine learning model offered an 86 percent AUC for predicting MACE, which was 10 percent higher than CCTA alone and over 35 percent higher than the Framingham Risk Score.

The Reading Room Podcast: Emerging Concepts in Breast Cancer Screening and Health Equity Implications, Part 3

The Reading Room Podcast: Emerging Concepts in Breast Cancer Screening and Health Equity Implications, Part 3

Jeff Hall
September 1st 2023
Podcast

In the third episode of a three-part podcast, Anand Narayan, M.D., Ph.D., and Amy Patel, M.D., discuss the challenges of expanded breast cancer screening amid a backdrop of radiologist shortages and ever-increasing volume on radiology worklists.

FDA Clears AI-Enhanced Portfolio of Ultrasound Systems for Women with High-Risk Pregnancies

FDA Clears AI-Enhanced Portfolio of Ultrasound Systems for Women with High-Risk Pregnancies

Jeff Hall
January 28th 2025
Article

An array of AI-powered features and automated tools may lead to improved workflow and image quality with the Voluson Expert 22, 20 and 18 ultrasound systems.

The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring

The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring

Whitney J. Palmer
December 5th 2020
Podcast

Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.

Study Examines Prognostic Value of Baseline PSMA PET/CT Factors in Patients with mCRPC

Study Examines Prognostic Value of Baseline PSMA PET/CT Factors in Patients with mCRPC

Jeff Hall
January 24th 2025
Article

Doubling of total tumor volume on PSMA PET/CT is 41 percent more likely to reduce overall survival in patients with metastatic castration-resistant prostate cancer (mCRPC), according to new research.

Study: Contrast-Enhanced Ultrasound May Improve LI-RADS Assessment of High-Risk Indeterminate Liver Lesions

Study: Contrast-Enhanced Ultrasound May Improve LI-RADS Assessment of High-Risk Indeterminate Liver Lesions

Jeff Hall
January 23rd 2025
Article

For patients previously assessed with LI-RADS LR-4 and LR-M presentations based on MRI or CT findings, the use of contrast-enhanced ultrasound led to 30 percent of these patients having LR-5 assessments definitive for hepatocellular carcinoma.

© 2025 MJH Life Sciences

All rights reserved.